Invesco Ltd. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$583,529
-71.9%
31,322
-60.7%
0.00%
-100.0%
Q2 2023$2,073,022
-7.8%
79,793
+1.9%
0.00%0.0%
Q1 2023$2,248,202
-19.5%
78,280
-17.0%
0.00%0.0%
Q4 2022$2,791,162
+38.9%
94,296
+11.7%
0.00%0.0%
Q3 2022$2,009,000
+4.7%
84,430
-1.8%
0.00%0.0%
Q2 2022$1,919,000
-10.7%
85,973
+0.5%
0.00%0.0%
Q1 2022$2,148,000
-30.4%
85,551
-0.7%
0.00%0.0%
Q4 2021$3,086,000
-19.3%
86,136
-4.1%
0.00%0.0%
Q3 2021$3,822,000
-7.5%
89,797
-5.9%
0.00%0.0%
Q2 2021$4,133,000
+2.8%
95,464
-3.1%
0.00%0.0%
Q1 2021$4,020,000
-5.0%
98,562
+5.4%
0.00%0.0%
Q4 2020$4,233,000
+14.8%
93,507
-10.2%
0.00%0.0%
Q3 2020$3,687,000
-20.2%
104,164
-14.9%
0.00%
-50.0%
Q2 2020$4,621,000
+27.8%
122,458
-2.1%
0.00%0.0%
Q1 2020$3,616,000
-47.0%
125,102
-5.0%
0.00%0.0%
Q4 2019$6,825,000
-6.2%
131,637
-0.7%
0.00%0.0%
Q3 2019$7,274,000
+73.7%
132,530
+28.5%
0.00%
+100.0%
Q2 2019$4,188,000
-0.3%
103,099
-25.8%
0.00%0.0%
Q1 2019$4,200,000
-20.4%
138,876
-11.6%
0.00%
-50.0%
Q4 2018$5,279,000
-41.3%
157,071
-26.3%
0.00%
-33.3%
Q3 2018$8,994,000
+120.2%
213,220
+67.1%
0.00%
+200.0%
Q2 2018$4,084,000
+9.6%
127,632
+70.3%
0.00%0.0%
Q1 2018$3,727,000
+29.8%
74,954
+40.7%
0.00%0.0%
Q4 2017$2,872,000
+3.8%
53,266
+11.6%
0.00%0.0%
Q3 2017$2,768,000
-71.0%
47,717
-75.3%
0.00%
-66.7%
Q2 2017$9,547,000
+379.7%
193,494
+322.5%
0.00%
+200.0%
Q1 2017$1,990,000
-4.4%
45,801
+7.7%
0.00%0.0%
Q4 2016$2,082,000
-7.7%
42,535
-9.7%
0.00%0.0%
Q3 2016$2,255,000
-21.6%
47,114
-12.2%
0.00%0.0%
Q2 2016$2,877,000
+52.8%
53,636
+27.4%
0.00%0.0%
Q1 2016$1,883,000
-4.2%
42,097
-18.3%
0.00%0.0%
Q4 2015$1,965,000
+26.7%
51,506
+5.7%
0.00%0.0%
Q3 2015$1,551,000
+13.4%
48,722
+17.7%
0.00%0.0%
Q2 2015$1,368,000
-15.2%
41,403
+5.6%
0.00%0.0%
Q1 2015$1,613,000
+13.3%
39,189
+12.1%
0.00%0.0%
Q4 2014$1,424,000
+0.5%
34,965
-9.6%
0.00%0.0%
Q3 2014$1,417,000
-75.4%
38,670
-68.9%
0.00%
-50.0%
Q2 2014$5,758,000
+2.1%
124,268
-9.4%
0.00%0.0%
Q1 2014$5,638,000
+46.3%
137,182
+35.9%
0.00%0.0%
Q4 2013$3,853,000100,9590.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders